Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients
Condition(s):Malignant Gliomas; Radiotherapy; PARP InhibitorLast Updated:January 3, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Malignant Gliomas; Radiotherapy; PARP InhibitorLast Updated:January 3, 2024Recruiting
Condition(s):High-grade GliomaLast Updated:April 29, 2021Unknown status
Condition(s):Malignant Glioma; Brain Tumor, RecurrentLast Updated:March 27, 2024Completed
Condition(s):GliomaLast Updated:May 17, 2023Recruiting
Condition(s):Progesterone Induced Blocking Factor in Endometrial CancerLast Updated:August 18, 2017Completed
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:June 3, 2014Completed
Condition(s):Quality of Life; Brain Tumor; Glioblastoma; Glioma; Anaplastic AstrocytomaLast Updated:August 14, 2023Completed
Condition(s):Glioma; NeoplasmsLast Updated:March 29, 2016Unknown status
Condition(s):Adult Anaplastic Astrocytoma; Adult Giant Cell Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain TumorLast Updated:October 18, 2017Completed
Condition(s):Primary Malignant Brain TumorsLast Updated:May 9, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.